These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 24101149)
1. Discontinuing anticoagulation following successful atrial fibrillation ablation in patients with prior strokes. Winkle RA; Mead RH; Engel G; Kong MH; Patrawala RA J Interv Card Electrophysiol; 2013 Dec; 38(3):147-53. PubMed ID: 24101149 [TBL] [Abstract][Full Text] [Related]
2. Current Status and Clinical Outcomes of Oral Anticoagulant Discontinuation After Ablation for Atrial Fibrillation in Japan - Findings From the AF Frontier Ablation Registry. Okumura Y; Nagashima K; Arai M; Watanabe R; Yokoyama K; Matsumoto N; Otsuka T; Suzuki S; Hirata A; Murakami M; Takami M; Kimura M; Fukaya H; Nakahara S; Kato T; Shimizu W; Iwasaki YK; Hayashi H; Harada T; Nakajima I; Okumura K; Koyama J; Tokuda M; Yamane T; Momiyama Y; Tanimoto K; Soejima K; Nonoguchi N; Ejima K; Hagiwara N; Harada M; Sonoda K; Inoue M; Kumagai K; Hayashi H; Satomi K; Yazaki Y; Watari Y; Circ J; 2019 Nov; 83(12):2418-2427. PubMed ID: 31619591 [TBL] [Abstract][Full Text] [Related]
3. Risk of stroke or transient ischemic attack after atrial fibrillation ablation with oral anticoagulant use guided by ECG monitoring and pulse assessment. Riley MP; Zado E; Hutchinson MD; Lin D; Bala R; Garcia FC; Callans DJ; Cooper JM; Verdino RJ; Dixit S; Marchlinski FE J Cardiovasc Electrophysiol; 2014 Jun; 25(6):591-6. PubMed ID: 24533561 [TBL] [Abstract][Full Text] [Related]
4. Risk of Stroke and Recurrence After AF Ablation in Patients With an Initial Event-Free Period of 12 Months. Kochhäuser S; Alipour P; Haig-Carter T; Trought K; Hache P; Khaykin Y; Wulffhart Z; Pantano A; Tsang B; Birnie D; Verma A J Cardiovasc Electrophysiol; 2017 Mar; 28(3):273-279. PubMed ID: 27933666 [TBL] [Abstract][Full Text] [Related]
5. Very low risk of thromboembolic events in patients undergoing successful catheter ablation of atrial fibrillation with a CHADS2 score ≤3: a long-term outcome study. Saad EB; d'Avila A; Costa IP; Aryana A; Slater C; Costa RE; Inácio LA; Maldonado P; Neto DM; Camiletti A; Camanho LE; Polanczyk CA Circ Arrhythm Electrophysiol; 2011 Oct; 4(5):615-21. PubMed ID: 21841192 [TBL] [Abstract][Full Text] [Related]
6. The safety of discontinuation of oral anticoagulation therapy after apparently successful atrial fibrillation ablation: a report from the Chinese Atrial Fibrillation Registry study. Yang WY; Du X; Jiang C; He L; Fawzy AM; Wang L; Liu C; Xia SJ; Chang SS; Guo XY; Li SN; Tang RB; Liu N; Bai R; Sang CH; Jiang CX; Yu RH; Long DY; Dong JZ; Lip GYH; Ma CS Europace; 2020 Jan; 22(1):90-99. PubMed ID: 31909431 [TBL] [Abstract][Full Text] [Related]
7. Anticoagulation use and clinical outcomes after catheter ablation in patients with persistent and longstanding persistent atrial fibrillation. Liang JJ; Elafros MA; Mullen MT; Muser D; Hayashi T; Enriquez A; Pathak RK; Zado ES; Santangeli P; Arkles JS; Schaller RD; Supple GE; Frankel DS; Garcia FC; Deo R; Lin D; Riley MP; Nazarian S; Dixit S; Marchlinski FE; Callans DJ J Cardiovasc Electrophysiol; 2018 Jun; 29(6):823-832. PubMed ID: 29513397 [TBL] [Abstract][Full Text] [Related]
8. Comparison of CHADS2 and CHA2DS2-VASC anticoagulation recommendations: evaluation in a cohort of atrial fibrillation ablation patients. Winkle RA; Mead RH; Engel G; Kong MH; Patrawala RA Europace; 2014 Feb; 16(2):195-201. PubMed ID: 24036378 [TBL] [Abstract][Full Text] [Related]
9. Discontinuation of oral anticoagulation and risk of stroke and death after ablation for typical atrial flutter: A nation-wide Danish cohort study. Giehm-Reese M; Johansen MN; Kronborg MB; Jensen HK; Gerdes C; Kristensen J; Johannessen A; Jacobsen PK; Djurhuus MS; Hansen PS; Riahi S; Nielsen JC Int J Cardiol; 2021 Jun; 333():110-116. PubMed ID: 33647366 [TBL] [Abstract][Full Text] [Related]
15. Real-world investigation on discontinuation of oral anticoagulation after paroxysmal atrial fibrillation catheter ablation in China. Yu R; Xi H; Lu J; Xu F; Shi L; Kong Q; Hu Y; Zhao X; Liu N Ann Palliat Med; 2020 May; 9(3):940-946. PubMed ID: 32434352 [TBL] [Abstract][Full Text] [Related]
16. A more specific anticoagulation regimen is required for patients after the cox-maze procedure. Ad N; Henry L; Shuman DJ; Holmes SD Ann Thorac Surg; 2014 Oct; 98(4):1331-8. PubMed ID: 25152383 [TBL] [Abstract][Full Text] [Related]
17. Anticoagulation after catheter ablation of atrial fibrillation: An unnecessary evil? A systematic review and meta-analysis. Proietti R; AlTurki A; Di Biase L; China P; Forleo G; Corrado A; Marras E; Natale A; Themistoclakis S J Cardiovasc Electrophysiol; 2019 Apr; 30(4):468-478. PubMed ID: 30575175 [TBL] [Abstract][Full Text] [Related]
18. "As Needed" nonvitamin K antagonist oral anticoagulants for infrequent atrial fibrillation episodes following atrial fibrillation ablation guided by diligent pulse monitoring: A feasibility study. Zado ES; Pammer M; Parham T; Lin D; Frankel DS; Dixit S; Marchlinski FE J Cardiovasc Electrophysiol; 2019 May; 30(5):631-638. PubMed ID: 30706975 [TBL] [Abstract][Full Text] [Related]
19. Anticoagulation after catheter ablation of atrial fibrillation guided by implantable cardiac monitors. Zuern CS; Kilias A; Berlitz P; Seizer P; Gramlich M; Müller K; Duckheim M; Gawaz M; Schreieck J Pacing Clin Electrophysiol; 2015 Jun; 38(6):688-93. PubMed ID: 25753968 [TBL] [Abstract][Full Text] [Related]
20. Oral anticoagulation is frequently discontinued after ablation of paroxysmal atrial fibrillation despite previous stroke: data from the German Ablation Registry. Nührich JM; Kuck KH; Andresen D; Steven D; Spitzer SG; Hoffmann E; Schumacher B; Eckardt L; Brachmann J; Lewalter T; Hochadel M; Senges J; Willems S; Hoffmann BA Clin Res Cardiol; 2015 Jun; 104(6):463-70. PubMed ID: 25537233 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]